ALPS Advisors’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-76,630
| Closed | -$290K | – | 991 |
|
2024
Q3 | $290K | Sell |
76,630
-746
| -1% | -$2.82K | ﹤0.01% | 963 |
|
2024
Q2 | $309K | Buy |
+77,376
| New | +$309K | ﹤0.01% | 832 |
|
2021
Q4 | – | Sell |
-89,040
| Closed | -$597K | – | 889 |
|
2021
Q3 | $597K | Sell |
89,040
-6,655
| -7% | -$44.6K | 0.01% | 480 |
|
2021
Q2 | $759K | Sell |
95,695
-34,310
| -26% | -$272K | 0.01% | 447 |
|
2021
Q1 | $989K | Buy |
130,005
+121
| +0.1% | +$920 | 0.01% | 399 |
|
2020
Q4 | $672K | Buy |
+129,884
| New | +$672K | 0.01% | 440 |
|
2019
Q4 | – | Sell |
-134,736
| Closed | -$667K | – | 815 |
|
2019
Q3 | $667K | Sell |
134,736
-6,636
| -5% | -$32.9K | 0.01% | 421 |
|
2019
Q2 | $785K | Sell |
141,372
-21,335
| -13% | -$118K | 0.01% | 381 |
|
2019
Q1 | $822K | Buy |
162,707
+7,029
| +5% | +$35.5K | 0.01% | 373 |
|
2018
Q4 | $1.47M | Buy |
+155,678
| New | +$1.47M | 0.01% | 249 |
|
2017
Q2 | – | Sell |
-47,658
| Closed | -$485K | – | 768 |
|
2017
Q1 | $485K | Sell |
47,658
-5,577
| -10% | -$56.8K | ﹤0.01% | 496 |
|
2016
Q4 | $691K | Buy |
+53,235
| New | +$691K | 0.01% | 245 |
|